Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Omnia Pharmaceuticals is a specialized pharmaceutical company headquartered in Hürth, Germany, dedicated to the development and distribution of high-quality generic drugs. The company focuses on niche therapeutic segments, particularly oncology, neurology, and rheumatology, offering cost-effective alternatives to off-patent brand-name medications. Omnia's portfolio includes a variety of small molecule formulations, such as injectables and oral solids, which are distributed across the European market. Through its expertise in regulatory affairs and supply chain management, Omnia Pharmaceuticals ensures the availability of essential medicines for hospitals and specialized healthcare providers. The company operates as a lean organization, leveraging strategic partnerships for manufacturing while maintaining internal control over product licensing and market access.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Omnia Pharmaceutical.